000 | 01556 a2200457 4500 | ||
---|---|---|---|
005 | 20250516101527.0 | ||
264 | 0 | _c20121212 | |
008 | 201212s 0 0 eng d | ||
022 | _a0391-1977 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGalli-Tsinopoulou, A | |
245 | 0 | 0 |
_aTwo-year cyclic infusion of pamidronate improves bone mass density and eliminates risk of fractures in a girl with osteoporosis due to Hajdu-Cheney syndrome. _h[electronic resource] |
260 |
_bMinerva endocrinologica _cSep 2012 |
||
300 |
_a283-9 p. _bdigital |
||
500 | _aPublication Type: Case Reports; Journal Article | ||
650 | 0 | 4 | _aAbnormalities, Multiple |
650 | 0 | 4 |
_aAcro-Osteolysis _xdrug therapy |
650 | 0 | 4 |
_aBone Density _xdrug effects |
650 | 0 | 4 |
_aBone Density Conservation Agents _xadministration & dosage |
650 | 0 | 4 | _aChild |
650 | 0 | 4 |
_aDiphosphonates _xadministration & dosage |
650 | 0 | 4 | _aDrug Administration Schedule |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 |
_aHajdu-Cheney Syndrome _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInfusion Pumps |
650 | 0 | 4 |
_aOsteoporosis _xdrug therapy |
650 | 0 | 4 |
_aOsteoporotic Fractures _xetiology |
650 | 0 | 4 | _aPamidronate |
650 | 0 | 4 | _aPedigree |
650 | 0 | 4 |
_aSpinal Fractures _xdrug therapy |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aKyrgios, I | |
700 | 1 | _aGiza, S | |
700 | 1 | _aGiannopoulou, E Z | |
700 | 1 | _aMaggana, I | |
700 | 1 | _aLaliotis, N | |
773 | 0 |
_tMinerva endocrinologica _gvol. 37 _gno. 3 _gp. 283-9 |
|
999 |
_c21921893 _d21921893 |